Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from SoftOx Solutions AS ( (DE:6FV) ) is now available.
SoftOx Solutions AS has announced a decision by its board of directors to issue up to 60 million shares under a financing facility with Long State Investments Limited. This move initiates a 10-day pricing period, with the subscription price primarily based on the VWAP of the company’s shares, and aims to secure investment through a private placement, potentially impacting the company’s financial standing and market operations.
More about SoftOx Solutions AS
SoftOx Solutions AS is a clinical-stage pharmaceutical company listed on Euronext Growth Oslo, focusing on developing pan-antimicrobial pharmaceuticals that target bacteria, viruses, and fungi. The company’s technology is developed in collaboration with leading Nordic research institutes.
YTD Price Performance: 592.86%
Average Trading Volume: 20,940,786
Current Market Cap: NOK220.1M
Find detailed analytics on 6FV stock on TipRanks’ Stock Analysis page.